These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25217698)

  • 1. Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1.
    Won H; Nandakumar V; Yates P; Sanchez S; Jones L; Huang XF; Chen SY
    Blood; 2014 Oct; 124(17):2647-56. PubMed ID: 25217698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis.
    Kingston D; Schmid MA; Onai N; Obata-Onai A; Baumjohann D; Manz MG
    Blood; 2009 Jul; 114(4):835-43. PubMed ID: 19465690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation.
    Mousa M; Liang Y; Tung LT; Wang H; Krawczyk C; Langlais D; Nijnik A
    Immunology; 2024 May; 172(1):109-126. PubMed ID: 38316548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU.1 is essential for CD11c expression in CD8(+)/CD8(-) lymphoid and monocyte-derived dendritic cells during GM-CSF or FLT3L-induced differentiation.
    Zhu XJ; Yang ZF; Chen Y; Wang J; Rosmarin AG
    PLoS One; 2012; 7(12):e52141. PubMed ID: 23284905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation.
    Anderson KL; Smith KA; Perkin H; Hermanson G; Anderson CG; Jolly DJ; Maki RA; Torbett BE
    Blood; 1999 Oct; 94(7):2310-8. PubMed ID: 10498603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1.
    Nandakumar V; Chou Y; Zang L; Huang XF; Chen SY
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3927-36. PubMed ID: 24062447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation.
    Nijnik A; Clare S; Hale C; Raisen C; McIntyre RE; Yusa K; Everitt AR; Mottram L; Podrini C; Lucas M; Estabel J; Goulding D; ; ; Adams N; Ramirez-Solis R; White JK; Adams DJ; Hancock RE; Dougan G
    Blood; 2012 Feb; 119(6):1370-9. PubMed ID: 22184403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of B cell development by the histone H2A deubiquitinase MYSM1.
    Jiang XX; Nguyen Q; Chou Y; Wang T; Nandakumar V; Yates P; Jones L; Wang L; Won H; Lee HR; Jung JU; Müschen M; Huang XF; Chen SY
    Immunity; 2011 Dec; 35(6):883-96. PubMed ID: 22169041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2-mediated inhibition of dendritic cell development correlates with decreased CD135 expression and increased monocyte/macrophage precursors.
    Guerrero AD; Dong MB; Zhao Y; Lau-Kilby A; Tarbell KV
    Immunology; 2014 Dec; 143(4):640-50. PubMed ID: 24954893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
    Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid development is selectively disrupted in PU.1 null mice.
    Anderson KL; Smith KA; Conners K; McKercher SR; Maki RA; Torbett BE
    Blood; 1998 May; 91(10):3702-10. PubMed ID: 9573007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner.
    Carotta S; Dakic A; D'Amico A; Pang SH; Greig KT; Nutt SL; Wu L
    Immunity; 2010 May; 32(5):628-41. PubMed ID: 20510871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation.
    Wang T; Nandakumar V; Jiang XX; Jones L; Yang AG; Huang XF; Chen SY
    Blood; 2013 Oct; 122(16):2812-22. PubMed ID: 24014243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYSM1/miR-150/FLT3 inhibits B1a cell proliferation.
    Jiang XX; Liu Y; Li H; Gao Y; Mu R; Guo J; Zhang J; Yang YM; Xiao F; Liu B; Wang C; Shen B; Chen SY; Li Z; Yang G
    Oncotarget; 2016 Oct; 7(42):68086-68096. PubMed ID: 27590507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell development requires histone deacetylase activity.
    Chauvistré H; Küstermann C; Rehage N; Klisch T; Mitzka S; Felker P; Rose-John S; Zenke M; Seré KM
    Eur J Immunol; 2014 Aug; 44(8):2478-88. PubMed ID: 24810486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Regulation of Antibody Responses by the Histone H2A Deubiquitinase MYSM1.
    Jiang XX; Chou Y; Jones L; Wang T; Sanchez S; Huang XF; Zhang L; Wang C; Chen SY
    Sci Rep; 2015 Sep; 5():13755. PubMed ID: 26348977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the c-fms proto-oncogene mediated by granulocyte/macrophage colony-stimulating factor (GM-CSF) in murine cell lines.
    Helftenbein G; Krusekopf K; Just U; Cross M; Ostertag W; Niemann H; Tamura T
    Oncogene; 1996 Feb; 12(4):931-5. PubMed ID: 8632916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development.
    Onai N; Obata-Onai A; Tussiwand R; Lanzavecchia A; Manz MG
    J Exp Med; 2006 Jan; 203(1):227-38. PubMed ID: 16418395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell-Specific Expression of RALDH2.
    Yashiro T; Yamaguchi M; Watanuki Y; Kasakura K; Nishiyama C
    J Immunol; 2018 Dec; 201(12):3677-3682. PubMed ID: 30413670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.